Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Blood (2012) 120 (21): 57.

https://doi.org/10.1182/blood.V120.21.57.57

Published: 2012

Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Blood (2011) 118 (21): 331.

https://doi.org/10.1182/blood.V118.21.331.331

Published: 2011

Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Blood (2011) 118 (21): 4110.

https://doi.org/10.1182/blood.V118.21.4110.4110

Published: 2011

Journal Articles

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Blood (2010) 116 (21): 3565.

https://doi.org/10.1182/blood.V116.21.3565.3565

Published: 2010

Journal Articles

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Blood (2010) 116 (21): 3566.

https://doi.org/10.1182/blood.V116.21.3566.3566

Published: 2010

Journal Articles

High Degree of Hematological Response After Pegylated Interferon Alpha-2a Therapy In Myeloproliferative Neoplasms

Jan Samuelsson, MD, PhD, Gerd Larfars, MD, PhD, Eva Ottosson, MD, PhD, Mats Merup, MD, PhD

Blood (2010) 116 (21): 5055.

https://doi.org/10.1182/blood.V116.21.5055.5055

Published: 2010

Journal Articles

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Blood (2010) 116 (21): 2395.

https://doi.org/10.1182/blood.V116.21.2395.2395

Published: 2010

Journal Articles

Apoptosis Gene Expression Profiling in Chronic Lymphocytic Leukemia Using Multiplex Ligation-Dependent Probe Amplification.

Maria Norberg, Marie Sevov, Mahmoud Mansouri, Gerard Tobin, Mats Merup, Anna Åleskog, Kenneth Nilsson, Richard Rosenquist

Blood (2009) 114 (22): 3457.

https://doi.org/10.1182/blood.V114.22.3457.3457

Published: 2009

Journal Articles

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Blood (2006) 108 (11): 401.

https://doi.org/10.1182/blood.V108.11.401.401

Published: 2006

Journal Articles

Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.

Andrea Pellagatti, Martin Jädersten, Ann-Mari Forsblom, Helen Cattan, Birger Christensson, Emma K. Emanuelsson, Mats Merup, Lars Nilsson, Jan Samuelsson, Birgitta Sander, James S. Wainscoat, Jacqueline Boultwood, Eva Hellström-Lindberg

Blood (2006) 108 (11): 855.

https://doi.org/10.1182/blood.V108.11.855.855

Published: 2006

Journal Articles

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Blood (2006) 107 (7): 2889–2894.

https://doi.org/10.1182/blood-2005-06-2227

Published: 2006

Includes: Supplemental data

Journal Articles

RITA Activates p53 Function in Chronic Lymphocytic Leukaemia Cells and Induces Apoptosis.

Hareth Nahi, MD, Mats Merup, MD/PhD, Lars Möllgård, MD/PhD, Galina Selivanova, Christer Paul

Blood (2005) 106 (11): 5536.

https://doi.org/10.1182/blood.V106.11.5536.5536

Published: 2005

Journal Articles

Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.

Martin Jädersten, MD, Andrea Pellagatti, Ann-Mari Forsblom, Emma K. Emanuelsson, Mats Merup, MD, Jan Samuelsson, MD, James S. Wainscoat, Jacqueline Boultwood, Eva Hellström-Lindberg, MD

Blood (2005) 106 (11): 3438.

https://doi.org/10.1182/blood.V106.11.3438.3438

Published: 2005

Journal Articles

Distinctive gene expression pattern in V H 3-21 utilizing B-cell chronic lymphocytic leukemia

Susann Fält, Mats Merup, Gerard Tobin, Ulf Thunberg, Gösta Gahrton, Richard Rosenquist, Anders Wennborg

Blood (2005) 106 (2): 681–689.

https://doi.org/10.1182/blood-2004-10-4073

Published: 2005

Includes: Supplemental data

Journal Articles

A Phase II Trial of Pegylated Interferon α-2b in Polycythemia Vera and Essential Thrombocythemia. Clinical Responses, Effects on PRV-1 Expression and Impact on Quality of Life.

Jan Samuelsson, MD, PhD, Hans Hasselbalch, Oystein Bruserud, Heike Pahl, Mats Merup, Olle Linder, Yvonne Brandberg, Poul Gram-Hansen, Magnus Bjorkholm, Waleed Ghanima, Claes Malm, Berit Markevarn, Torben Mourits-Andersen, Peter Johansson, Lars Nilsson, Gunnar Birgegard

Blood (2004) 104 (11): 1518.

https://doi.org/10.1182/blood.V104.11.1518.1518

Published: 2004

Journal Articles

Disruption of the Hexb/Enc-1 Antisense Gene and Identification of Elevated Enc-1 Expression in Patients with Hairy Cell Leukemia.

Mikael Lerner, Marianne Hammarsund, PhD, Olle Sangfelt, PhD, Chaoyong Zhu, PhD, Mats Merup, MD, PhD, Monika Jansson, Goesta Gahrton, MD, PhD, Hanneke Kluin-Nelemans, MD, PhD, Stefan Einhorn, MD, PhD, Dan Grander, MD, PhD, Martin Corcoran, PhD

Blood (2004) 104 (11): 1538.

https://doi.org/10.1182/blood.V104.11.1538.1538

Published: 2004

Journal Articles

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Karin Karlsson, Fiona Murray, Anna Laurell, Kerstin Willander, Gunilla Enblad, Mats Merup, Juhani Vilpo, Gunnar Juliusson, Christer Sundström, Ola Söderberg, Göran Roos, Richard Rosenquist

Blood (2004) 104 (9): 2879–2885.

https://doi.org/10.1182/blood-2004-01-0132

Published: 2004

Journal Articles

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Gerard Tobin, Ulf Thunberg, Anna Johnson, Inger Eriksson, Ola Söderberg, Karin Karlsson, Mats Merup, Gunnar Juliusson, Juhani Vilpo, Gunilla Enblad, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2003) 101 (12): 4952–4957.

https://doi.org/10.1182/blood-2002-11-3485

Published: 2003

Journal Articles

6q Deletions in Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphomas

Mats Merup, Teresa Calero Moreno, Mats Heyman, Kristina Rönnberg, Dan Grandér, Rut Detlofsson, Omid Rasool, Yie Liu, Stefan Söderhäll, Gunnar Juliusson, Gösta Gahrton, Stefan Einhorn

Blood (1998) 91 (9): 3397–3400.

https://doi.org/10.1182/blood.V91.9.3397

Published: 1998

Journal Articles

Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia

Martin M. Corcoran, Omid Rasool, Yie Liu, Arati Iyengar, Dan Grander, Rachel E. Ibbotson, Mats Merup, Xiushan Wu, Vadim Brodyansky, Anne C. Gardiner, Gunnar Juliusson, Robert M. Chapman, Ganka Ivanova, Mary Tiller, Gosta Gahrton, Nick Yankovsky, Eugene Zabarovsky, David G. Oscier, Stefan Einhorn

Blood (1998) 91 (4): 1382–1390.

https://doi.org/10.1182/blood.V91.4.1382

Published: 1998

NARROW

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

High Degree of Hematological Response After Pegylated Interferon Alpha-2a Therapy In Myeloproliferative Neoplasms

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

Apoptosis Gene Expression Profiling in Chronic Lymphocytic Leukemia Using Multiplex Ligation-Dependent Probe Amplification.

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Lenalidomide Up-Regulates SPARC and Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome Patients with 5q Deletion.

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

RITA Activates p53 Function in Chronic Lymphocytic Leukaemia Cells and Induces Apoptosis.

Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.

Distinctive gene expression pattern in V H 3-21 utilizing B-cell chronic lymphocytic leukemia

A Phase II Trial of Pegylated Interferon α-2b in Polycythemia Vera and Essential Thrombocythemia. Clinical Responses, Effects on PRV-1 Expression and Impact on Quality of Life.

Disruption of the Hexb/Enc-1 Antisense Gene and Identification of Elevated Enc-1 Expression in Patients with Hairy Cell Leukemia.

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

6q Deletions in Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphomas

Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only